PL2588480T3 - Pochodne 3,4-dihydropirolo[1,2-a]pirazyno-2,8(1H)-dikarboksyamidowe, ich otrzymywanie i zastosowania terapeutyczne - Google Patents

Pochodne 3,4-dihydropirolo[1,2-a]pirazyno-2,8(1H)-dikarboksyamidowe, ich otrzymywanie i zastosowania terapeutyczne

Info

Publication number
PL2588480T3
PL2588480T3 PL11781590T PL11781590T PL2588480T3 PL 2588480 T3 PL2588480 T3 PL 2588480T3 PL 11781590 T PL11781590 T PL 11781590T PL 11781590 T PL11781590 T PL 11781590T PL 2588480 T3 PL2588480 T3 PL 2588480T3
Authority
PL
Poland
Prior art keywords
dihydropyrrolo
pyrazine
preparation
therapeutic use
dicarboxamide derivatives
Prior art date
Application number
PL11781590T
Other languages
English (en)
Inventor
Sylvain Cote-Des-Combes
Jacques Froissant
Jean-François Gibert
Frank Marguet
Christophe Pacaud
Frédéric Puech
Antoine Ravet
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42697541&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2588480(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi filed Critical Sanofi
Publication of PL2588480T3 publication Critical patent/PL2588480T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL11781590T 2010-06-03 2011-06-01 Pochodne 3,4-dihydropirolo[1,2-a]pirazyno-2,8(1H)-dikarboksyamidowe, ich otrzymywanie i zastosowania terapeutyczne PL2588480T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1054372A FR2960876B1 (fr) 2010-06-03 2010-06-03 Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique.
EP11781590.2A EP2588480B1 (en) 2010-06-03 2011-06-01 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof

Publications (1)

Publication Number Publication Date
PL2588480T3 true PL2588480T3 (pl) 2017-08-31

Family

ID=42697541

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11781590T PL2588480T3 (pl) 2010-06-03 2011-06-01 Pochodne 3,4-dihydropirolo[1,2-a]pirazyno-2,8(1H)-dikarboksyamidowe, ich otrzymywanie i zastosowania terapeutyczne

Country Status (38)

Country Link
US (2) US8791119B2 (pl)
EP (1) EP2588480B1 (pl)
JP (1) JP5995841B2 (pl)
KR (1) KR20130113928A (pl)
CN (1) CN103168041B (pl)
AR (1) AR081832A1 (pl)
AU (1) AU2011268651B2 (pl)
BR (1) BR112012030697A2 (pl)
CA (1) CA2801154C (pl)
CL (1) CL2012003360A1 (pl)
CO (1) CO6602113A2 (pl)
CR (1) CR20120595A (pl)
CY (1) CY1118512T1 (pl)
DK (1) DK2588480T3 (pl)
DO (1) DOP2012000296A (pl)
EA (1) EA201291364A1 (pl)
EC (1) ECSP12012322A (pl)
ES (1) ES2603420T3 (pl)
FR (1) FR2960876B1 (pl)
GT (1) GT201200319A (pl)
HR (1) HRP20161494T1 (pl)
HU (1) HUE030650T2 (pl)
IL (1) IL223364A (pl)
LT (1) LT2588480T (pl)
MA (1) MA34360B1 (pl)
MX (1) MX2012014084A (pl)
NI (1) NI201200176A (pl)
NZ (1) NZ603947A (pl)
PE (1) PE20130259A1 (pl)
PL (1) PL2588480T3 (pl)
PT (1) PT2588480T (pl)
SG (1) SG186143A1 (pl)
SI (1) SI2588480T1 (pl)
TN (1) TN2012000520A1 (pl)
TW (1) TWI487707B (pl)
UY (1) UY33428A (pl)
WO (1) WO2011161537A2 (pl)
ZA (1) ZA201209071B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2960876B1 (fr) * 2010-06-03 2012-07-27 Sanofi Aventis Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique.
UY35834A (es) * 2013-11-14 2015-05-29 Bristol Myers Squibb Company Una Corporación Del Estado De Delaware Piperazinas de pirazolo sustituido como inhibidores de caseína quinasa 1 delta y epsilon
JP6307989B2 (ja) * 2014-04-02 2018-04-11 住友化学株式会社 塩、酸発生剤、レジスト組成物及びレジストパターンの製造方法
CN110709523B (zh) * 2017-04-12 2023-07-11 豪夫迈·罗氏有限公司 使用经pictet spengler反应获得的加标签的核苷的测序反应方法
JP2020528062A (ja) * 2017-07-27 2020-09-17 江蘇恒瑞医薬股▲ふん▼有限公司 ピペラジンヘテロアリール誘導体、その製造方法、およびその医薬での使用
TW202412758A (zh) * 2022-06-29 2024-04-01 香港商英矽智能科技知識產權有限公司 Fgfr2與fgfr3抑制劑及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1150991B1 (en) 1999-02-01 2004-04-07 University of Virginia Patent Foundation Compositions for treating inflammatory response
MXPA04002243A (es) * 2001-09-19 2004-06-29 Aventis Pharma Sa Compuestos quimicos.
GB0202015D0 (en) * 2002-01-29 2002-03-13 Hoffmann La Roche Piperazine Derivatives
ATE428711T1 (de) 2003-12-11 2009-05-15 Aventis Pharma Inc Substituierte 1h-pyrroloä3,2-b, 3,2-c und 2,3- cüpyridin-2-carbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i- epsilon
GB0328900D0 (en) 2003-12-12 2004-01-14 Glaxo Group Ltd Novel compounds
US8304408B2 (en) * 2007-05-24 2012-11-06 The Regents Of The University Of California Wnt signaling inhibitors, and methods for making and using them
NZ582871A (en) 2007-07-27 2011-09-30 Sanofi Aventis 1,2,3,4-Tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5- tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof
EP2229395A1 (en) * 2008-01-17 2010-09-22 Grünenthal GmbH Substituted sulfonamide derivatives
WO2009097515A2 (en) * 2008-01-30 2009-08-06 Wyeth [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
FR2960876B1 (fr) * 2010-06-03 2012-07-27 Sanofi Aventis Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
CN103168041B (zh) 2015-08-26
MA34360B1 (fr) 2013-07-03
CO6602113A2 (es) 2013-01-18
CA2801154A1 (en) 2011-12-29
ECSP12012322A (es) 2013-03-28
CL2012003360A1 (es) 2013-04-01
US9233965B2 (en) 2016-01-12
SG186143A1 (en) 2013-01-30
DK2588480T3 (en) 2016-12-12
EA201291364A1 (ru) 2013-05-30
HRP20161494T1 (hr) 2016-12-16
AU2011268651A1 (en) 2012-12-20
NI201200176A (es) 2013-02-06
TWI487707B (zh) 2015-06-11
FR2960876A1 (fr) 2011-12-09
SI2588480T1 (sl) 2016-12-30
DOP2012000296A (es) 2013-02-28
CA2801154C (en) 2018-01-09
KR20130113928A (ko) 2013-10-16
JP2013527226A (ja) 2013-06-27
UY33428A (es) 2011-12-30
TN2012000520A1 (en) 2014-04-01
PE20130259A1 (es) 2013-03-22
US8791119B2 (en) 2014-07-29
CN103168041A (zh) 2013-06-19
AU2011268651B2 (en) 2016-09-01
GT201200319A (es) 2014-01-17
FR2960876B1 (fr) 2012-07-27
MX2012014084A (es) 2013-01-29
TW201202248A (en) 2012-01-16
HUE030650T2 (en) 2017-05-29
CY1118512T1 (el) 2017-07-12
CR20120595A (es) 2013-01-03
PT2588480T (pt) 2016-11-21
WO2011161537A2 (en) 2011-12-29
WO2011161537A3 (en) 2012-03-01
EP2588480B1 (en) 2016-08-17
US20140336189A1 (en) 2014-11-13
ES2603420T3 (es) 2017-02-27
NZ603947A (en) 2014-12-24
BR112012030697A2 (pt) 2019-09-24
EP2588480A2 (en) 2013-05-08
AR081832A1 (es) 2012-10-24
LT2588480T (lt) 2016-12-12
ZA201209071B (en) 2014-02-26
US20130090340A1 (en) 2013-04-11
IL223364A (en) 2015-06-30
JP5995841B2 (ja) 2016-09-21

Similar Documents

Publication Publication Date Title
ZA201006728B (en) Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-a]pyridine derivatives,and preparation and therapeutic use thereof
ZA201004154B (en) Tetrahydro-imidazo[1,5-a]pyrazine derivatives,preparation methods and medical uses thereof
IL216226A0 (en) Cyclopenta [c] pyrrole-2-carboxylate derivatives, preparation thereof, and therapeutic use thereof
PL2262803T3 (pl) Wielopodstawione pochodne 2-arylo-6-fenyloimidazo[1,2-A]pirydyn, ich wytwarzanie i ich zastosowanie w lecznictwie
IL201450A0 (en) Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
PL2448940T3 (pl) Pochodne 6,7,8,9-tetrahydro-pirymido{1,2-a} pirymidyn-4-onu, ich wytwarzanie i zastosowanie farmaceutyczne
ZA201107284B (en) Tetrahydro-imidazo[1,5-a]pyrazine derivatives salts, preparation methods and medicinal use thereof
IL206673A0 (en) Imidazo[1,2-a]pyridine-2-carboxamide derivatives, their preparation and their therapeutic application
ZA201209071B (en) 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof
IL215286A0 (en) 9h-pyrrolo[2,3-b:5,4-c]dipridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
SG10201403138WA (en) Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof and pharmaceutical use thereof
ZA201307511B (en) Pyrido [2,3-b] pyrazine derivatives and their therapeutical uses
IL206671A0 (en) N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
IL220448A (en) Pyridine [3,2 - d] Pyrimidine - 7 (8h) - Their medical uses and uses
EP2578586A4 (en) HEXAHYDROPYRROLO [3,4-B] PYRROLE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF
IL206669A0 (en) 6-HETEROCYCLIC IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
HK1205504A1 (en) Substituted pyrazolo[1,5-a]pyridines, their preparation and use as medicaments [1,5-a]
ZA201004520B (en) N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds,preparation thereof and therapeutic application thereof
ZA201100251B (en) Substituted 1-benzyl-cinnolin-4(1h)-one derivatives,preparation thereof,and therapeutic use thereof
ZA201004641B (en) Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides,preparation thereof and therapeutic application thereof
IL215733A0 (en) 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof
IL206672A0 (en) N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
IL206667A0 (en) 2-HETEROAROYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
IL206665A0 (en) 2-BENZOYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF